{
  "nctId": "NCT07180069",
  "briefTitle": "Phosphate Diet Strategies to Lower Blood Phosphate in Dialysis Patients",
  "officialTitle": "Dietary Strategies for Hyperphosphatemia: A Randomized Controlled Study on the Effectiveness of Phosphate-Specific Interventions in Reducing Serum Phosphate Levels in Hemodialysis Patients in a Dialysis Center",
  "protocolDocument": {
    "nctId": "NCT07180069",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2025-09-11",
    "uploadDate": "2025-09-11T14:03",
    "size": 1392394,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT07180069/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 200,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2024-10-01",
    "completionDate": "2025-01-01",
    "primaryCompletionDate": "2025-01-01",
    "firstSubmitDate": "2025-07-20",
    "firstPostDate": "2025-09-18"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Males and females aged 18-60 years\n* Stage 5 CKD patients on hemodialysis\n* Receiving ≥2 weekly dialysis sessions for ≥2 months\n* Written informed consent provided\n* Ability (patient/caregiver) to read, write, and speak Arabic\n\nExclusion Criteria:\n\n* Age \\<18 or \\>60\n* Receiving \\<2 dialysis sessions per week or \\<2 months duration\n* Refusal or inability to provide consent\n* Severe mental illness or cognitive impairment\n* Acute illness, infection, or hospitalization at enrollment\n* Malabsorption conditions or prior GI surgery\n* Noncompliance with medication or dialysis regimen",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "60 Years",
    "stdAges": [
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in serum phosphate concentration measured by standard blood test (mg/dL)",
        "description": "The primary outcome is the change in serum phosphate level from baseline to 12 weeks. Serum phosphate will be measured using venous blood samples and analyzed with an automated chemistry analyzer in the hospital laboratory.",
        "timeFrame": "Baseline and at weeks 4,8 and week 12"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 0,
      "exclusionCount": 0,
      "totalCount": 0
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 35,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T05:06:11.775Z",
  "dataSource": "ClinicalTrials.gov API v2 - Ultimate Complete Collection"
}